o-MethoxycinnamaldehydeCAS# 1504-74-1 |
- 2-Methoxycinnamaldehyde
Catalog No.:BCX0617
CAS No.:60125-24-8
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
| Cas No. | 1504-74-1 | SDF | Download SDF |
| PubChem ID | 641298 | Appearance | White-pale yellow crystals |
| Formula | C10H10O2 | M.Wt | 162.2 |
| Type of Compound | Phenols | Storage | Desiccate at -20°C |
| Synonyms | o-Methoxycinnamic aldehyde | ||
| Solubility | Soluble in ethanol and methan | ||
| Chemical Name | (E)-3-(2-methoxyphenyl)prop-2-enal | ||
| SMILES | COC1=CC=CC=C1C=CC=O | ||
| Standard InChIKey | KKVZAVRSVHUSPL-GQCTYLIASA-N | ||
| Standard InChI | InChI=1S/C10H10O2/c1-12-10-7-3-2-5-9(10)6-4-8-11/h2-8H,1H3/b6-4+ | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
| Description | o-Methoxycinnamaldehyde from cinnamon has antibiotic activity, it is a competitive inhibitor against CYP1A2 while it was a mixed type inhibitor against CYP2E. |
| Targets | P450 (e.g. CYP17) |
| In vivo | Metabolism of the cinnamon constituent o-methoxycinnamaldehyde in the rat.[Pubmed: 3765663]Xenobiotica. 1986 Sep;16(9):845-52.
|
| Kinase Assay | Identification of inhibitory component in cinnamon--O-methoxycinnamaldehyde inhibits CYP1A2 and CYP2E1-.[Pubmed: 15618674]Drug Metabolism & Pharmacokinetics, 2002, 17(3):229-36.The Cinnamomi Cortex and Ephedra Herba were found to more strongly inhibit aminopyrine N-demethylation in rat liver microsomes compared to other constituents included in Sho-seiryu-to. |
o-Methoxycinnamaldehyde Dilution Calculator
o-Methoxycinnamaldehyde Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 6.1652 mL | 30.8261 mL | 61.6523 mL | 123.3046 mL | 154.1307 mL |
| 5 mM | 1.233 mL | 6.1652 mL | 12.3305 mL | 24.6609 mL | 30.8261 mL |
| 10 mM | 0.6165 mL | 3.0826 mL | 6.1652 mL | 12.3305 mL | 15.4131 mL |
| 50 mM | 0.1233 mL | 0.6165 mL | 1.233 mL | 2.4661 mL | 3.0826 mL |
| 100 mM | 0.0617 mL | 0.3083 mL | 0.6165 mL | 1.233 mL | 1.5413 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Pemetrexed disodium
Catalog No.:BCN2179
CAS No.:150399-23-8
- MRS 2690
Catalog No.:BCC7514
CAS No.:15039-58-4
- SR 49059
Catalog No.:BCC7324
CAS No.:150375-75-0
- Sivelestat sodium salt
Catalog No.:BCC2368
CAS No.:150374-95-1
- threo-7-O-Methylguaiacylglycerol beta-coniferyl ether
Catalog No.:BCN6929
CAS No.:150333-85-0
- Quipazine dimaleate
Catalog No.:BCC6727
CAS No.:150323-78-7
- Cyclopropyl 2-fluorobenzyl ketone
Catalog No.:BCC8923
CAS No.:150322-73-9
- Prasugrel
Catalog No.:BCC1089
CAS No.:150322-43-3
- Z-Aib-OH
Catalog No.:BCC3150
CAS No.:15030-72-5
- H-Aib-Ome.HCl
Catalog No.:BCC2671
CAS No.:15028-41-8
- Ledipasvir D-tartrate
Catalog No.:BCC4047
CAS No.:1502654-87-6
- Fmoc-p-amino-benzoic acid,Fmoc-4-Abz-OH
Catalog No.:BCC2622
CAS No.:15026-42-1
- L-NIL hydrochloride
Catalog No.:BCC5706
CAS No.:150403-89-7
- epi-Eudesmol
Catalog No.:BCN1670
CAS No.:15051-81-7
- Fmoc-Lys(Dde)-OH
Catalog No.:BCC3518
CAS No.:150629-67-7
- Tolvaptan
Catalog No.:BCC5096
CAS No.:150683-30-0
- 5-Methoxycanthin-6-one
Catalog No.:BCN3326
CAS No.:15071-56-4
- Calyxamine B
Catalog No.:BCN1671
CAS No.:150710-72-8
- Drynachromoside A
Catalog No.:BCN7891
CAS No.:1507388-29-5
- Gap19
Catalog No.:BCC5599
CAS No.:1507930-57-5
- Oxybutynin chloride
Catalog No.:BCC4149
CAS No.:1508-65-2
- Tropicamide
Catalog No.:BCC4574
CAS No.:1508-75-4
- Retigabine
Catalog No.:BCC6427
CAS No.:150812-12-7
- Retigabine dihydrochloride
Catalog No.:BCC1890
CAS No.:150812-13-8
Metabolism of the cinnamon constituent o-methoxycinnamaldehyde in the rat.[Pubmed:3765663]
Xenobiotica. 1986 Sep;16(9):845-52.
The metabolism of o-Methoxycinnamaldehyde (1.3 mmol/kg, intragastrically) was studied in rats. Identification of the urinary metabolites by g.l.c.-mass spectrometry and quantification by h.p.l.c. showed that the major metabolic pathway (approx. two-thirds of the dose) was oxidation to the corresponding cinnamic and phenylpropionic acids (C6-C3 acids) which were largely excreted as glycine conjugates. Intermediate amounts (approx. 10% of the dose) of the O-demethylated C6-C3 acids were excreted. Relatively large amounts of the beta-hydroxylated phenylpropionic acid derivative were found, however only traces of the further products of beta-oxidation (2-methoxylated derivatives of benzoic and hippuric acid) were excreted. No evidence was obtained for conjugation of o-Methoxycinnamaldehyde with glutathione. Urinary excretion of metabolites was rapid (91% in 24 h and 98% in 48 h).
Identification of inhibitory component in cinnamon--O-methoxycinnamaldehyde inhibits CYP1A2 and CYP2E1-.[Pubmed:15618674]
Drug Metab Pharmacokinet. 2002;17(3):229-36.
The Cinnamomi Cortex and Ephedra Herba were found to more strongly inhibit aminopyrine N-demethylation in rat liver microsomes compared to other constituents included in Sho-seiryu-to. The component inhibiting drug oxidations catalyzed by CYP1A2 and CYP2E1 was isolated from Cinnamomi Cortex, and was identified as o-Methoxycinnamaldehyde (OMCA). When phenacetin and 4-nitrophenol were used as probe substrates for CYP1A2 and CYP2E1, respectively, the OMCA was shown to be a competitive inhibitor against CYP1A2 while it was a mixed type inhibitor against CYP2E1. The inhibitory effect of OMCA on 4-nitrophenol 2-hydroxylation (K(i)=6.3 microM) was somewhat potent compared to that observed on phenacetin O-deethylation (K(i)=13.7 microM) in rat liver microsomes.
